scispace - formally typeset
D

David E. Newby

Researcher at University of Edinburgh

Publications -  902
Citations -  45577

David E. Newby is an academic researcher from University of Edinburgh. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 98, co-authored 805 publications receiving 35865 citations. Previous affiliations of David E. Newby include NHS Lothian & Queen's University.

Papers
More filters
Journal ArticleDOI

Contrast-enhanced computed tomography assessment of aortic stenosis

TL;DR: In this article, the authors assessed aortic valve calcific and non-calcific disease using contrast-enhanced CT using a post hoc analysis of 164 patients (median age 71 (IQR 66-77) years, 78% male) with aortric stenosis (41 mild, 89 moderate, 34 severe; 7% bicuspid).
Book ChapterDOI

Unsupervised Learning for Cross-Domain Medical Image Synthesis Using Deformation Invariant Cycle Consistency Networks

TL;DR: This paper presents a deformation-invariant CycleGAN (DicycleGAN) method using deformable convolutional layers and new cycle-consistency losses that has displayed its ability to generate synthesized data that is aligned with the source while maintaining a proper quality of signal compared to CycleGAN-generated data.
Journal ArticleDOI

The vascular effects of rotigaptide in vivo in man.

TL;DR: Augmentation of connexin 43 communication has no effect on basal vascular tone and does not enhance endothelium-dependent or independent vasodilatation, or t-PA release in the forearm arterial circulation of healthy men.
Journal ArticleDOI

Non-invasive assessment of coronary artery bypass graft patency using 16-slice computed tomography angiography

TL;DR: Computed tomography is an accurate, rapid and non-invasive method of assessing coronary artery bypass graft patency, however, this was achieved at the expense of an increase in radiation dose.
Journal ArticleDOI

Efficacy of metformin in pregnant obese women: a randomised controlled trial

TL;DR: A double-masked randomised placebo-controlled trial to determine whether metformin given to obese pregnant women from 16 weeks’ gestation until delivery reduces the incidence of high birthweight babies.